|
7:00 am
|
Registration and Continental Breakfast
|
|
7:15 am
|
Welcoming Remarks and Introductions
Sudipto Mukherjee, MD, PhD, MPH
|
|
7:20 am
|
Clonal Hematopoiesis - Aftermath of the Mutant Clones
Abhay Singh, MD, MPH
|
|
7:40 am
|
Myelodysplastic Neoplasms - Something Old and Something New for the Good and the Ugly
Esther Natalie Oliva, MD
|
|
8:00 am
|
AML (Acute Myeloid Leukemia) - Evolving Definitions and Changing Treatment Paradigms
Uma M. Borate, MBBS, MS
|
|
8:20 am
|
Interactive Case-Based Discussion and Questions
Abhay Singh, MD, MPH, Esther Natalie Oliva, MD, and Uma M. Borate, MBBS, MS
|
|
8:40 am
|
MPN (Myeloproliferative Neoplasms) - An Unfinished Story of JAK Inhibitors and Beyond
Kristen Marie Pettit, MD
|
|
9:00 am
|
AA & PNH (Aplastic Anemia & Paroxysmal Nocturnal Hemoglobinuria) - Finding Ways to Resuscitate a Dying Marrow
Austin Kulasekararaj, MD, PhD, MPH
|
|
9:20 am
|
Cellular Therapies for AML (Acute Myeloid Leukemia) - Cellular Engineering to Fight Wayward Cells
Marco Davila, MD, PhD
|
|
9:40 am
|
Interactive Case-Based Discussion and Questions
Kristen Marie Pettit, MD, Austin Kulasekararaj, MD, PhD, MPH, and Marco Davila, MD, PhD
|
|
10:00 am
|
Adjourn
|
|
A 5-minute question and answer period is included in each speaker’s allotted time.
|
